Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xin Gan
Institution:
First Affiliated Hospital of Nanchang University
Observed institutions:
Nanchang University,
Jiangxi Provincial People's Hospital,
First Affiliated Hospital of Nanchang University
ORCID:
0000-0001-8917-5795
Observed ORCID:
0000-0001-8917-5795
OpenAlex ID:
A5101679157
Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling
2015
·
Xin Gan
, Zhentian Liu
, et al.
·
Tumor Biology
·
43
High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR
2020
·
Chuanhui Chen
, Shanshan Peng
, et al.
·
Molecular and Cellular Biochemistry
·
23
Efficacy and safety of PD1/PDL1 blockades versus docetaxel in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis
2018
·
Jixiang Liu
, Yulan Zhong
, et al.
·
OncoTargets and Therapy
·
17
PDF
The phenomena of balanced effect between α-globin gene and of β-globin gene
2018
·
Liangying Zhong
, Xin Gan
, et al.
·
BMC Medical Genetics
·
12
PDF
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial
2026
·
Fan Zhang
, Zhendong Zheng
, et al.
·
Signal Transduction and Targeted Therapy
·
3
PDF
Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis
2026
·
Bo Zhang
, Runbo Zhong
, et al.
·
Nature Communications
·
2
PDF
Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1–positive non-small cell lung cancer in the HARMONi–2 study
2025
·
Lei Wang
, Wenxiu Yao
, et al.
·
Future Oncology
·
1
PDF
A retrospective real-world study on the efficacy and safety of anlotinib in combination with immunotherapy as maintenance therapy after standard immunochemotherapy for extensive-stage small cell lung cancer (ALTER-L059).
2026
·
Yong Fang
, Lei Pan
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
8
Citation count:
101
H-index:
4
I10-index:
4
Year
Topic
Type